Molecular genetics of psychopathologies: A search for simple answers to complex problems

Behavior Genetics

Volumn 26, Issue 3, 1996, Pages 325-333

  Ginsburg, Benson E ^a,b   Werick, Theresa M ^a,b   Escobar, Javier I ^b,c   Kugelmass, Sol ^d   Treanor, John J ^e   Wendtland, Leigh ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e Buffalo Psychiatric Center   (United States)

Author keywords

clozapine; dopamine receptors; pedigree; phenotype; Psychopathology; psychopharmacology; schizophrenia

Indexed keywords

DOPAMINE RECEPTOR;

DNA LIBRARY; GENETIC LINKAGE; HUMAN; MENTAL DISEASE; MOLECULAR GENETICS; PEDIGREE; REVIEW; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CLOZAPINE; EXONS; FEMALE; GENE EXPRESSION; GENOTYPE; HUMANS; MALE; PHENOTYPE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0030009090     PISSN: 00018244     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02359388     Document Type: Review

References (58)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th ed., American Psychiatric Association, Washington, DC.
2. Andreasen, N. C., Arndt, S., Swayze, V, 2nd, Cizadlo, T., Flaum, M., O'Leary, D., Ehrhardt, J. C., and Yuh, W. T. (1994). Thalamic abnormalities in schizophrenia visualized, through magnetic resonance image averaging. Science 266 (5183):294-298.
3. Aschauer, H. N., Aschauer-Treiber, G., Isenberg, K. E., Todd, R. D., Knesevich, M. A., Garver, D. L., Reich, T., and Cloninger, C. R., (1990). No evidence for linkage between chromosome 5 markers and schizophrenia Hum. Hered. 40:109-115.
4. Barker, P. E. (1990). Gene mapping and cystic fibrosis. Am. J. Med. Sci. 299(1):69-72.
5. Bassett, A. S. (1989), Chromosome 5 and schizophrenia: Implications for genetic linkage studies. Schizo. Bull. 15(3): 392-402.
6. Blackwood, D., St. Clair, D., and Muir, W. J. (1991a). DNA markers and biological vulnerability markers in families multiply affected with schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 240:191-196.
7. Blackwood, D. H. R., St. Clair, D. M., Muir, W. J., and Duffy, J. C. (1991b). Auditory P300 and eye tracking dysfunction in schizophrenic pedigrees. Arch. Gen. Psychiatry 48: 889-909.
8. Canetti, L., Shalev, A. V., and De-Nour, A. K. (1994). Israeli adolescents' norms of the Brief Symptom Inventory (BSI). Israeli J. Psychiatry Related Sci. 31(1):13-18.
9. Catalano, M., Nobile, M., Novelli, E., Nothen, M. M., and Smeralsdi, E. (1993). Distribution of a novel mutation in the first exon of the human dopamine D4 receptor gene in psychotic patients. Biol. Psychiatry 34(7):549-564.
10. Ciaranello, R. D., and Ciaranello, A. L. (1991). Genetics of major psychiatric disorders. Annu. Rev. Med. 42:151-158.
11. Clementz, B. A., Grove, W. M., Iacano, W. G., and Sweeney, J. A. (1992). Smooth-pursuit eye movement dysfunction and liability for schizophrenia: implications for genetic modeling. J. Abnorm. Psychol. 101(1):117-129.
12. Coon, H., Byerley, W., Holik, J., Hoff, M., Myles-Worsley, M., Lannfelt, L., Sokoloff, P., Schwartz, J. C., Waldo, M., and Freedman, R. (1993). Linkage analysis of schizophrenia with five dopamine receptor genes in nine pedigrees. Am. J. Hum. Genet. 52(2):327-334.
13. Crowe, R. R., Black, D. W., Andreasen, N. C., and Huether, M., (1990). The Iowa multiplex family study of schizophrenia: Linkage analysis on chromosome 5. Eur. Arch. Psychiatry Clin. Neurosci. 239:290-292.
14. Crowe, R. R., Black, D. W., Wesner, R., Andreasen, N. C., Cookman, A., and Roby, J. (1991). Lack of linkage to chromosome 5q11-q13 markers in six schizophrenia pedigrees. Arch. Gen. Psychiatry 48:357-361.
15. Davis, K. L., Kahn, R. S., Grant, K., and Davidson, M. (1991). Dopamine in schizophrenia: A review and reconceptualization. Am. J. Psychiatry 148:1474-1486.
16. Detera-Wadleigh, S., Goldin, L., Sherrington, R. Encio, I., De Miguel, E., Barrettini, W., and Gurling, H. (1989). Exclusion of linkage to 5q11-q13 in families with schizophrenia and other psychiatric disorders. Nature 340:391-393.
17. Egeland, J. A., Gerhard, D. S., Pauls, D. L., Sussex, J. N., Kidd, K. K., Allen, C. R., Hostetter, A. M., and Housman, D., (1987). Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 325:783-787.
18. Erlenmeyr-Kimling, L., and Cornblatt, B. A. (1987a). High-risk research in schizophrenia: A summary of what has been learned. J. Psychiat. Res. 21(4):401-411.
19. Erlenmeyr-Kimling, L., and Cornblatt, B. A. (1987b). The New York High-Risk Project: A follow-up report. Schizo. Bull. 13:439-450.
20. Epstein, E. E., Ginsburg, B. E., Hesselbrock, V. M., and Schwarz, J. C. (1994). Alcohol and drug abusers subtyped by antisocial personality and primary and secondary depressive disorder. Ann. N.Y. Acad. Sci. 708:187-201.
21. Ginsburg, B. E. (1958). Genetics as a tool in the study of behavior. Perspect. Biol. Med. 1:397-424.
22. Ginsburg, B. E. (1966). All mice are not created equal: recent findings on genes and behavior. Soc. Serv. Rev. 40:121-134.
23. Ginsburg, B. E. (1971). Developmental genetics of behavioral capacities: The nature-nurture problem re-evaluated. Merrill-Palmer Quarterly of Behavior and Development. 17: 59-66.
24. Ginsburg, B. E., and Kugelmass, S. (1994). Affective dimensions of schizophrenia - Genetic links to affective disorders. In Frijda, N. (ed.), Summaries of the Proceedings of the International Society for Research on Emotions. ISRE Publications, Storrs, Connecticut.
25. Hallmayer, J., Maier, W., Ackenheil, M., Ertl, M. A., Schmidt, S., Mingles, J., Lichtermann, D., and Wildenauer, D. (1992). Evidence against linkage of schizophrenia to chromosome 5q11-q13 markers in systematically ascertained families. Biol. Psychiatry 31:83-94.
26. Holzman, P. S., Proctor, L. R., and Hughes, D. W. (1973). Eye tracking patterns in schizophrenia. Science 181:179-181.
27. Holzman, P. S., Proctor, L. R., and Levy, D. L. (1974). Eye tracking dysfunctions in schizophrenic patients and their relatives. Arch. Gen. Psychiatry 31:143-151.
28. Holzman, P. S., Kringlen, E., Levy, D. L., Proctor, L. R., and Haberman, S. J., (1977). Abnormal-pursuit eye movements in schizophrenia: Evidence for a genetic indicator. Arch. Gen. Psychiatry 34:802-805.
29. Holzman, P. S., Kringlen, E., Levy, D. L., and Haberman, S. J. (1980). Deviant eye tracking in twins discordant for psychosis. Arch. Gen. Psychiatry 37:627-631.
30. Holzman, P. S., Kringlen, E., Matthysse, S., Flanagan, S. D., Lipton, R. B., Cramer, G., Levin, S., Lang, S., and Levy, D. L. (1988). A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch. Gen. Psychiatry 45:641-647.
31. Iacano, W. G., Bassett, A. S., and Jones, B. D., (1988). Eye tracking dysfunction is associated with partial trisomy of chromosome 5 and schizophrenia. Arch. Gen. Psychiatry 45:1140-1141.
32. Iacano, W. G., Moreau, M., Beiser, M., Fleming, J. A. E., and Tsung-Yi, L. (1992). Smooth pursuit eye tracking in first episode psychotic patients and their relatives. J. Abnorm. Psychol. 101(1):104-116.
33. Johnstone, E. C., Crow, T. J., Frith, C. D., Husband, J., and Kreel, L. (1976). Cerebral ventricle size and cognitive impairment in chronic schizophrenia. Lancet 2:924-926.
34. Katsanis, J., Iacono, W. G., and Beiser, M., (1991). Relationship of lateral ventricular size to psychophysiological measures and short-term outcome. Psychiatry Res. 37(2): 115-129.
35. Kaufman, C. A., DeLisi, L., Lehner, T., and Gilliam, T. C. (1989). Physical mapping, linkage analysis of a putative schizophrenia locus on chromosome 5q. Schizo. Bull. 15(3):441-452.
36. Kemali, D., Maj, M., and Galderisi, S. (1986). Clinical, biological and neuropsychological features associated with lateral ventricular enlargement in DSM-III schizophrenic disorder. Psychiatry Res. 21:137-149.
37. Kennedy, J. L., Giuffra, L. A., Moises, H., Cavelli-Sforza, L. L., Pakstis, A. J., Kidd, K. K., Castiglione, C. M., Sjogren, B., Wettenberger, L., and Kidd, J. R. (1988). Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish pedigree. Nature 336:167-170.
38. Kugelmass, S., and Ginsburg, B. E., (1994). Two Israeli studies of high risk for schizophrenia and major affective disorder. In Frijda, N. (ed.), Summaries of the Proceedings of the International Society for Research on Emotions. ISRE Publications, Storrs, Connecticut.
39. Lifshitz, M., Kugelmass, S., and Karov, M. (1985). Perceptual-motor and memory performance of high risk children. Schizo. Bull. 11:74-84.
40. Matthyse, S. (1974). Dopamine and the pharmacology of schizophrenia: the state of the evidence. J. Psychiat. Res. 11:107-113.
41. McGillivray, B. C., Bassett, A. S., Langlois, S., Pantzar, T., and Wood, S. (1990). Familial 5q11.2-q13.3 segmental duplication cosegregating with multiple anomalies, including schizophrenia. Am. J. Med. Genet. 35:10-13.
42. McGuffin, P., Sargeant, M., Hetti, G., Tidmarsh, S., Whatley, S., and Marchbanks, R. M. (1990). Exclusion of a schizophrenia susceptibility gene from the chromosome 5q11-q13 region: New data and a reanalysis of previous reports. Am. J. Hum. Genet. 47:535-536.
43. Meltzer, H. Y., and Stahl, S. M., (1976). The dopamine hypothesis of schizophrenia: A review. Schizo. Bull. 2:19-76.
44. Nanko, S., Hattori, M., Ikeda, K., Sasaki, T., Kazamatsuri, H., and Kuwata, S. (1993). Dopamine D4 receptor polymorphism and schizophrenia. Lancet 341(8846):689-690.
45. Overall, J. E., and Gorham, D. R. (1962). The brief psychiatric rating scale. Psychol. Rep. 10:799-812.
46. Overall, J. E., Hollister, L. E., and Pichot, P. (1967). Major psychiatric disorders: A four-dimensional model. Arch. Gen. Psychiatry 16:146-151.
47. Pakkenberg, B. (1987). Post-mortem studies of chronic schizophrenic brains. Br. J. Psychiatry 151:744-752.
48. Rao, P. A., Pickar, D., Gejman, P. V., et al. (1994). Allelic variation in the D4 dopamine receptor does not predict response to clozapine. Arch. Gen. Psychiatry 51:912-917.
49. St. Clair, D., Blackwood, D., Muir, W., Baillie, D., Hubbard, A., Wright, A., and Evans, J. (1989). No linkage of 5q11-q13 markers to schizophrenia in Scottish families. Nature 339:305-309.
50. Seeman, P. (1987). Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1:133-152.
51. Seeman, P., (1992). Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychophamacology 7(4):261-284.
52. Sherrington, R., Brynjolfsson, J., Petursson, H. Potter, M., Dudleston, K., Barraclough, B., Wasmuth, J., Dobbs, M., and Gurling, H. (1988). Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336: 164-167.
53. Sommer, S. S., Lind, T. J., Heston, L. L., and Sobell, J. L. (1993). Dopamine D4 receptor variants in unrelated schizophrenic cases and controls. Am. J. Med. Genet. 48(2): 90-93.
54. Tsui, L. P., Buchwald, M., Barker, D., Braman, J., Knowlton, R. K., Schumm, J. W., Eiberg, H., and Mohr, J. (1985). Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science 230:1054-1067.
55. Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., and Civelli, O., (1991). Cloning of the gene for a human D4 dopamine receptor with high affinity for the antipsychotic clozapine. Nature 350:610-614.
56. Van Tol, H. H. M., Wu, C. M., Guan, H.-C. Ohara, K., Bunzow, J. R., Civelli, O., Kennedy, J., Seeman, P., Niznik, H. B., and Jovanovic, V. (1992). Multiple dopamine D4 receptor variants in the human population. Nature 358: 149-152.
57. Weinberger, D. R., Torrey, E. F., Neophytides, A. N., and Wyatt, R. J. (1979). Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch. Gen. Psychiatry 36: 735-739.
58. Werick, T. M., Wendtland, L. C., Ginsburg, B. E., Escobar, J. I., and Treanor, J. J. (1994). Genetic variations of the D4 dopamine receptor associated with subtypes of schizophrenia and responses to neuroleptic agents. Behav. Genet. 24:537.